Literature DB >> 4624098

Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.

J E Sokal, C W Aungst, T Han.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4624098

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

2.  Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria.

Authors:  A Lamensans; L Chedid; E Lederer; J P Rosselet; R H Gustafson; H J Spencer; B Ludwig; F M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Eradication of microscopic metastases with intratumoral injection of bacillus Calmette-Guerin.

Authors:  M Sakita; A Takenaka; T Yamane; M Kasuga; Y Fujita; S Majima
Journal:  Jpn J Surg       Date:  1984-09

4.  Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.

Authors:  G A Currie; T J McElwain
Journal:  Br J Cancer       Date:  1975-02       Impact factor: 7.640

5.  Enzyme activated alkylating agents.

Authors:  C R Ball; J A Double; J Goodban
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

6.  Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1973-07       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.